The effect of Empagliflozin on the ECG change of STEMI patients who underwent angioplasty ; A double blind randomized clinical trial study

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230926059531N1

Enrollment

116

Registered

2023-12-11

Start date

2023-12-11

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

STEMI patients who underwent angioplasty. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: under treatment with empagliflozin 10 mg tablets is taken orally daily. The manufacturer is Abidi Pharmaceutical Company. Intervention 2: Control group: under place

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute coronary syndrome(ST Elevation MI )

Exclusion criteria

Exclusion criteria: type 1 diabetic patients patients with GFR <30 Diabetic patient under treatment with empagliflozin Cardiogenic shock due to STEMI

Design outcomes

Primary

Measure	Time frame
ECG change of STEMI patients. Timepoint: The beginning of the study and 90th day. Method of measurement: Obtaining an ECG and checking the related changes that are mentioned in the questionnaire.;Left ventricular Ejection Fraction in STEMI patients. Timepoint: The beginning of the study ,40 th day and 90th day. Method of measurement: Obtaining echocardiography and checking the related changes that are mentioned in the questionnaire.;Exercise capacity in STEMI patients. Timepoint: The beginning of the study ,40 th day and 90th day. Method of measurement: The 6- minute walk test.	—

Measure

Time frame

ECG change of STEMI patients. Timepoint: The beginning of the study and 90th day. Method of measurement: Obtaining an ECG and checking the related changes that are mentioned in the questionnaire.;Left ventricular Ejection Fraction in STEMI patients. Timepoint: The beginning of the study ,40 th day and 90th day. Method of measurement: Obtaining echocardiography and checking the related changes that are mentioned in the questionnaire.;Exercise capacity in STEMI patients. Timepoint: The beginning of the study ,40 th day and 90th day. Method of measurement: The 6- minute walk test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Amel Shahbaz

Yazd University of Medical Sciences

sara.amelshahbaz@gmail.com+98 35 3525 5012

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026